When Recombinant Human IGF-II R/IGF2R is immobilized at 2 μg/mL (100 µL/well), the concentration of Recombinant Human CREG Recombinant Human CREG that produces 50% of the optimal binding response is found to be approximately 2‑10 ng/mL.
Purity ≥95% (SDS-PAGE) Endotoxin level ＜0.1 EU/μg Function IGF2R is a multifunctional receptor with binding sites for a variety of ligands, including insulin-like growth factor II (IGF2; 147470), retinoic acid (RA), TGF-β (TGFB1; 190180), urokinase-type plasminogen activator receptor (UPAR, or PLAUR; 173391) and mannose 6-phosphate (M6P), a modification characteristic of a lysosomal enzyme. IGF2R plays a major role in controlling IGF signaling by directing IGF2 to lysosomes, targeting lysosomal enzymes to lysosomes, and recycling lysosomal enzymes from the plasma membrane
When Recombinant Human IGF-II R/IGF2R is immobilized at 2 μg/mL (100 µL/well), the concentration of Recombinant Human CREG Recombinant Human CREG that produces 50% of the optimal binding response is found to be approximately 2‑10 ng/mL.
Lyophilized from 10mM PBS, 5% Trehalose, 5% Mannitol, pH 7.4
复溶
Reconstitute in sterile water to a concentration of 0.1-0.5 mg/ml.
储存条件
-20°C储存,避免反复冻融
运输条件
超低温运输
稳定性与储存
在 -20~-80℃ 下可保存 1 年以上。复溶后建议分装。避免冷冻/解冻循环。
图片
Recombinant Human IGF-II R/IGF2R Protein (rp167530) - SDS-PAGE 2 μg/lane of Recombinant Human IGF-II R/IGF2R Protein was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie® Blue staining, showing the band at 180 kDa under reducing conditions and 150 kDa under non-reducing conditions.
ZJ25F0825561
危险品化学品经营许可证（带存储）